LITE 10-Q report for 2025-12-27
This play collects the cover-page excerpt of Lumentum Holdings Inc.’s Form 10‑Q for the quarterly period ended December 27, 2025. The excerpt is limited to filing and registrant metadata (issuer name, CIK/filing number, principal office address, telephone, exchange and ticker). It does not include financial statements, management’s discussion & analysis, liquidity or risk-factor updates—so it offers confirmation that the company filed but contains no material operating or financial disclosures to change a thesis by itself.
Linked assets
Lumentum Holdings Inc. (LITE) — Nasdaq Global Select Market. The excerpt confirms the registrant name, commission file number (001-36861), principal address (1001 Ridder Park Drive, San Jose, California 95131), and that the company has electronically filed required reports and interactive data for the applicable period.
Lumentum Holdings Inc. (LITE) — Form 10‑Q cover page for quarter ended December 27, 2025. Confirms filing metadata (issuer, address, commission file no., Nasdaq listing) but contains no financial statements, MD&A, guidance, or material disclosures in the excerpt provided.
LITE 10-Q report for 2025-12-27 lite-20251227 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 27, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36861 Lumentum Holdings Inc. (Exact name of Registrant as specified in its charter) Delaware 47-3108385 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 1001 Ridder Park Drive , San Jose , California 95131 (Address of principal executive offices including Zip code) (408) 546-5483 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value of $0.001 per share LITE Nasdaq Global Select Market Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller repo"
Source proof
Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review
Source is the Form 10‑Q cover/header for the quarter ended December 27, 2025. The provided text is the SEC cover page: form type (10‑Q), period end date, issuer identification, exchange listing, and basic filing checkboxes. No financial statements, MD&A, guidance, material events, or risk factor updates were included in the excerpt.
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
The provided text is only the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.
This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.
This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.
This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.
The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.
Supporting authors
1 author contributed to this play. The excerpt is a primary filing cover page; analysis is limited to filing existence and metadata verification.
Unlock full thesis monitoring
Actionable insight: None beyond confirming that Lumentum filed a quarterly report. For a tradeable view, obtain and review the full 10‑Q (financial statements, MD&A, liquidity and risk disclosures) or subsequent company communications before adjusting positions. Recommended strategy on this play: sell (play-level recommendation).